June 22, 2024

Sequencing Consumables Market Size to Worth USD 50.75 Bn By 2033

The global sequencing consumables market size was valued at USD 6.94 billion in 2023 and is expected to reach around USD 50.75 billion by 2033 with a CAGR of 18.14% from 2024 to 2033.

Key Takeaways

  • Asia Pacific is expected to witness the fastest rate of growth in the sequencing consumables market during the forecast period.
  • By product, the kits segment held the largest segment of the sequencing consumables market in 2023.
  • By product, the reagents segment is expected to grow at a significant rate during the forecast period.
  • By platform, the second-generation sequencing consumables segment is expected to hold the dominating share of the market.
  • By platform, the third-generation sequencing consumables segment is expected to grow at a notable rate.
  • By application, the cancer diagnostics segment is expected to hold the dominating share of the market during the forecast period.
  • By application, the pharmacogenomics segment is expected to grow at a notable rate.

Sequencing Consumables Market Size 2024 To 2033

The sequencing consumables market plays a pivotal role in supporting advancements in genomics and molecular biology. As an integral component of DNA sequencing processes, consumables encompass a range of products such as reagents, sample preparation kits, and other laboratory supplies. This market is characterized by its dynamic nature, driven by the continuous evolution of sequencing technologies and the growing demand for genomic insights in various scientific disciplines.

Get a Sample: https://www.precedenceresearch.com/sample/3679

Growth Factors

The growth of the sequencing consumables market is propelled by the increasing adoption of next-generation sequencing (NGS) techniques across research, clinical diagnostics, and pharmaceutical applications. The rise in personalized medicine, coupled with decreasing costs of sequencing, further fuels the demand for consumables. Technological innovations, such as high-throughput sequencing platforms, contribute to market expansion by enhancing the efficiency and speed of sequencing workflows.

Sequencing Consumables Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 18.14%
Global Market Size in 2023 USD 6.94 Billion
Global Market Size by 2033 USD 50.75 Billion
U.S. Market Size in 2023 USD 2.53 Billion
U.S.Market Size by 2033 USD 13.39 Billion
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Product, By Platform, and By Application
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Plastic Processing Machinery Market Size to Attain USD 35.58 Bn By 2033

Market Dynamics

Drivers:

Several factors drive the demand for sequencing consumables, including the surge in genomic research initiatives, a growing awareness of precision medicine, and the escalating prevalence of genetic disorders. The expansion of research and development activities in life sciences and biotechnology also acts as a major driver. Additionally, the widening scope of applications in areas like oncology, agriculture, and forensics amplifies the need for reliable and efficient sequencing consumables.

Opportunities:

Opportunities within the sequencing consumables market lie in the untapped potential of emerging economies, where increasing healthcare infrastructure and research investments create a conducive environment for market growth. Continuous product innovations, such as improved reagents and streamlined sample preparation kits, present opportunities for market players to stay competitive. Collaborations between industry stakeholders and research institutions can foster innovation and create novel avenues for market expansion.

Challenges:

The sequencing consumables market faces challenges related to stringent regulatory requirements and quality standards, particularly in the context of clinical applications. Price pressure due to intense market competition poses a challenge for manufacturers. Additionally, addressing the ethical considerations associated with the use of genomic data and ensuring data privacy remain ongoing challenges that impact the market’s trajectory. Navigating these challenges requires a strategic approach and ongoing commitment to quality and compliance.

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Recent developments in the Sequencing Consumables Market

  • In October 2022, Illumina (US) collaborated with GenoScreen (France) to extend genomic testing accessibility for multidrug-resistant tuberculosis, particularly in countries heavily affected by tuberculosis. This partnership aims to enhance diagnostic capabilities and contribute to the global effort to combat tuberculosis.
  • In October 2022, Illumina (US) entered into a strategic research collaboration with AstraZeneca (UK). The partnership focuses on improving pharmaceutical pipelines by leveraging genomic insights to identify genetic variants associated with human diseases. This collaboration underscores the increasing importance of genomics in drug development and precision medicine.
  • In September 2022, Thermo Fisher Scientific (US) achieved FDA approval for the Oncomine Dx Target Test. This marked a milestone as the first Next-Generation Sequencing (NGS)-based companion diagnostic, designed to aid in therapy selection for patients with RET mutations/fusions in thyroid cancers. The FDA approval highlights the growing role of genomics in guiding personalized treatment decisions for cancer patients.

Sequencing Consumables Market Companies

  • Illumina, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • Qiagen N.V. (Netherlands)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Agilent Technologies, Inc. (US)
  • Pacific Biosciences of California, Inc. (US)
  • PerkinElmer, Inc. (US)
  • Oxford Nanopore Technologies Ltd. (UK)
  • Bio-Rad Laboratories, Inc. (US)
  • BGI Genomics Co., Ltd. (China)
  • GenScript Biotech Corporation (China)
  • Eurofins Scientific (Luxembourg)
  • Macrogen Inc. (South Korea)
  • New England Biolabs, Inc. (US)
  • Swift Biosciences, Inc. (US)

Segments Covered in the Report

By Product

  • Kits
  • Reagents
  • Accessories

By Platform

  • 1st Generation sequencing consumables
  • 2nd Generation sequencing consumables
  • 3rd Generation sequencing consumables

By Application

  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • Reproductive Health Diagnostics
  • Pharmacogenomics
  • Agrigenomics
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Sequencing Consumables Market 

5.1. COVID-19 Landscape: Sequencing Consumables Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Sequencing Consumables Market, By Product

8.1. Sequencing Consumables Market Revenue and Volume, by Product, 2024-2033

8.1.1 Kits

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Reagents

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Accessories

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Sequencing Consumables Market, By Platform

9.1. Sequencing Consumables Market Revenue and Volume, by Platform, 2024-2033

9.1.1. 1st Generation sequencing consumables

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. 2nd Generation sequencing consumables

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. 3rd Generation sequencing consumables

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Sequencing Consumables Market, By Application 

10.1. Sequencing Consumables Market Revenue and Volume, by Application, 2024-2033

10.1.1. Cancer Diagnostics

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Infectious Disease Diagnostics

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Reproductive Health Diagnostics

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Pharmacogenomics

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Agrigenomics

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

10.1.6. Others

10.1.6.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Sequencing Consumables Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

Chapter 12. Company Profiles

12.1. Illumina, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Thermo Fisher Scientific Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Qiagen N.V

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. F. Hoffmann-La Roche Ltd.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Agilent Technologies, Inc

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Pacific Biosciences of California, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. PerkinElmer, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Oxford Nanopore Technologies Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bio-Rad Laboratories, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. BGI Genomics Co., Ltd.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/


Leave a Reply

Your email address will not be published. Required fields are marked *